147 related articles for article (PubMed ID: 7569173)
1. Fluticasone propionate--an update on preclinical and clinical experience.
Fuller R; Johnson M; Bye A
Respir Med; 1995 Sep; 89 Suppl A():3-18. PubMed ID: 7569173
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory profile of fluticasone propionate.
Johnson M
Allergy; 1995; 50(23 Suppl):11-4. PubMed ID: 7604948
[TBL] [Abstract][Full Text] [Related]
3. Development of fluticasone propionate and comparison with other inhaled corticosteroids.
Johnson M
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S434-9. PubMed ID: 9563368
[TBL] [Abstract][Full Text] [Related]
4. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis.
Storms WW
J Asthma; 1998; 35(4):313-36. PubMed ID: 9669826
[TBL] [Abstract][Full Text] [Related]
5. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
Powell N; Till SJ; Kay AB; Corrigan CJ
Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953
[TBL] [Abstract][Full Text] [Related]
6. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
Holliday SM; Faulds D; Sorkin EM
Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.
Hagan JB; Kita H; Gleich GJ
Clin Exp Allergy; 1998 Aug; 28(8):999-1006. PubMed ID: 9756205
[TBL] [Abstract][Full Text] [Related]
9. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis.
Bryson HM; Faulds D
Drugs; 1992 May; 43(5):760-75. PubMed ID: 1379151
[TBL] [Abstract][Full Text] [Related]
10. Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis.
Wiseman LR; Benfield P
Drugs; 1997 May; 53(5):885-907. PubMed ID: 9129872
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma.
Staresinic AG; Sorkness CA
Expert Opin Pharmacother; 2000 Sep; 1(6):1227-44. PubMed ID: 11249490
[TBL] [Abstract][Full Text] [Related]
12. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B; Faulds D
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.
Corrigan CJ; Bungre JK; Assoufi B; Cooper AE; Seddon H; Kay AB
Eur Respir J; 1996 Oct; 9(10):2077-86. PubMed ID: 8902470
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone propionate for asthma prophylaxis.
Drug Ther Bull; 1994 Apr; 32(4):25-7. PubMed ID: 7635021
[TBL] [Abstract][Full Text] [Related]
15. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.
van As A; Bronsky EA; Dockhorn RJ; Grossman J; Lumry W; Meltzer EO; Seltzer JM; Rogenes PR
J Allergy Clin Immunol; 1993 Jun; 91(6):1146-54. PubMed ID: 8509578
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone versus beclomethasone or budesonide for chronic asthma.
Adams N; Bestall JM; Jones PW
Cochrane Database Syst Rev; 2002; (1):CD002310. PubMed ID: 11869636
[TBL] [Abstract][Full Text] [Related]
17. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.
Booth H; Richmond I; Ward C; Gardiner PV; Harkawat R; Walters EH
Am J Respir Crit Care Med; 1995 Jul; 152(1):45-52. PubMed ID: 7599861
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma.
Bootsma GP; Koenderman L; Dekhuijzen PN; Festen J; Lammers JW; van Herwaarden CL
Allergy; 1998 Jul; 53(7):653-61. PubMed ID: 9700034
[TBL] [Abstract][Full Text] [Related]
19. Nasal cytological changes following pharmacological intervention.
Meltzer EO
Allergy; 1995; 50(23 Suppl):15-20. PubMed ID: 7604949
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
